FDA Inspection
Biomat USA IncBiomat USA Inc – FDA Inspection, Mar 14, 2019
Record Details
This FDA Inspection record concerns Biomat USA Inc, with an inspection on March 14, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c4914351-cfb9-405c-a6b8-44b454c1c888
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1082533
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 15, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 8, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 20, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 28, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA Inc
- FDA Inspection 1002170 - 2017-02-15
- FDA Inspection 925809 - 2015-05-08
- FDA Inspection 812446 - 2012-12-20
- FDA Inspection 563661 - 2009-01-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.